During the past decade, Genesys Hurley Cancer Institute conducted 169 clinical trials. In the 10-year time frame, 169 clinical trials started and 204 clinical trials were completed, i.e. on average, 120.7% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 92 clinical trials were completed. i.e. 121.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesys Hurley Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 125 trials, followed by "Alliance for Clinical Trials in Oncology" with 104 trials sponsored, "SWOG Cancer Research Network" with 81 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored and "Eastern Cooperative Oncology Group" with 22 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesys Hurley Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 277 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "Canadian Cancer Trials Group" with 9 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Genesys Hurley Cancer Institute" are "Breast Cancer" (45 trials), "Lung Cancer" (32 trials), "Lymphoma" (14 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials) and "Prostate Cancer" (13 trials). Many other conditions were trialed in "Genesys Hurley Cancer Institute" in a lesser frequency.

Most popular intervention types in "Genesys Hurley Cancer Institute" are "Drug" (324 trials), "Other" (203 trials), "Biological" (137 trials), "Procedure" (78 trials) and "Radiation" (67 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (75 trials), "Quality-of-Life Assessment" (70 trials), "Questionnaire Administration" (40 trials), "placebo" (34 trials) and "Biospecimen Collection" (33 trials). Other intervention names were less common.

The vast majority of trials in "Genesys Hurley Cancer Institute" are 329 trials for "All" genders, 66 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Genesys Hurley Cancer Institute". undefined are not yet recruiting, 68 are recruiting, 125 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 185 completed trials in Genesys Hurley Cancer Institute, 7 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Genesys Hurley Cancer Institute, 12 "Phase 1" clinical trials were conducted, 209 "Phase 2" clinical trials and 191 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".

Genesys Hurley Cancer Institute has several departments that took part in Clinical trials: "Genesee Hematology Oncology PC" - 146 trials